Quantcast

Latest Influenza vaccine Stories

2014-08-27 23:13:03

Honoring National Immunization Awareness Month, New York Times and USA Today Best Selling author, Sanjay Jain, M.D. MBA explains how to identify and stay on top of immunizations for every age group. Washington, DC (PRWEB) August 27, 2014 The purpose behind vaccinations is to help "teach" the body how to effectively build up immunity for the future and fight off infectious agents that may cause disease. The immune system contains a diverse network of tissues, organs, and highly...

2014-08-27 08:26:54

BEIJING, Aug. 27, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2014 Annual General Meeting of Shareholders held on Wednesday, August 27, 2014 in Beijing, PRC. The required quorum, a majority of the common shares outstanding, was voted by proxy. The Company's shareholders approved the following proposals: -- The re-election of Weidong Yin, Yuk Lam Lo, Simon Anderson,...

2014-08-26 16:28:19

New Analysis Provides Basis for a Synthetic Mers CoV Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Mers CoV virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 2012. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Mers CoV Blocker-Vaccine(TM) candidate,...

2014-08-26 16:28:01

New Analysis Provides Basis for a Synthetic Influenza H1N1 Blocker-Vaccine Candidate, Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Influenza H1N1 virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 1918. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Influenza H1N1...

2014-08-26 12:28:34

New Analysis Provides Basis for a Synthetic Chikungunya Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Chikungunya virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 1953. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Chikungunya Blocker-Vaccine(TM)...

pregnant flu vaccine
2014-08-20 03:00:11

Group Health Research Institute Both mother and fetus are at increased risk for complications of flu infection during pregnancy. And prenatal care providers say they’re advising women to get the flu vaccine, in line with recommendations from various organizations. But many pregnant women don’t understand the importance of this advice—and don’t get the vaccine. Robert Arao, MPH, a biostatistician at Group Health Research Institute, did a statewide survey—the first of its...

2014-08-19 12:28:40

MERIDEN, Conn. and SCOTTSDALE, Ariz., Aug. 19, 2014 /PRNewswire/ -- Protein Sciences Corporation and Passport Health announced today that Flublok® influenza vaccine will be available this fall at all 230+ Passport Health locations across the United States. In addition, all employers who arrange their influenza vaccination clinics through Passport Health will be able to request Flublok. http://photos.prnewswire.com/prnvar/20140617/118909 "We created Flublok to save lives and our...

female Aedes aegypti mosquito
2014-08-18 06:41:22

April Flowers for redOrbit.com - Your Universe Online As if West Nile virus and malaria weren't enough, mosquitoes are now delivering the chikungunya virus, which was first identified in the early 1950s in East Africa. The virus, characterized by severe joint pain, headache and fever, has caused sporadic outbreaks in Africa, India and Thailand throughout the 1960s and 1970s. Now, as of 2013, it has reached the Western Hemisphere and there are no vaccines or specific drug treatments to deal...

2014-08-18 04:21:18

CYPRESS, Calif. and LONDON, Aug. 18, 2014 /PRNewswire-iReach/ -- Immune Targeting Systems (ITS), specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (Flunisyn(TM)) designed to protect humans from all strains of seasonal and pandemic influenza A. To determine the effectiveness of Flunisyn(TM) ITS produced its own live influenza challenge agent derived from the recently circulating Influenza A/California/2009 (H1N1)...

2014-08-14 12:28:41

-- Conference call scheduled for Friday, August 15, 2014 at 8:00 AM ET -- BEIJING, Aug. 14, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2014. Second Quarter 2014 Financial Highlights (compared to the second quarter 2013) -- Quarterly sales were $12.1 million, a decrease of 30.7% from $17.5 million in...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'